Nature Reviews Immunology Submission Guide

NRI publishes no day-by-day schedule. Its editorial process page describes the stages in order, and its metrics page gives two medians across all submissions: 11 days from submission to first editorial decision and 141 days from submission to acceptance (no year is printed with either figure). Treat both as aggregates, not promises.

• Commissioning or proposal. Articles by external authors are invited or commissioned by the in-house editors, and authors may propose Review-type and Comment-type articles as a synopsis through the online submission system, using the link and instructions provided by the editor.

• Submission. The article must not be under consideration at another journal.

• Initial editorial assessment. The editor assesses the organization, structure and accessibility of the article and may recommend changes to the manuscript and display items before formal peer review.

• Peer review. Review-type articles undergo external peer review by several experts in the field, single-blind. The editor returns the referee reports to the corresponding author and gives guidance on how to proceed.

• Revision. A formal rebuttal is required for articles where revisions are requested. If the editor considers the article adequately revised, it is accepted in principle.

• Editing, artwork, copy editing and proofs. In-house editors edit the text and display items, art editors redraw the figures after peer review, and authors review the final text and display items at the proof stage.

Source: Nature Reviews Immunology author guidelines, the Nature Reviews article format guides for Reviews and Perspectives, and the journal's editorial policies, read on 2026-10-09.

Use this page when you are still deciding:

• whether the topic has timing and novelty headroom relative to recent reviews

• whether the scope is broad enough for a broad immunology readership

• whether the author team's standing supports a Nature Reviews piece

• what the inquiry letter must accomplish

Before submitting a pre-submission inquiry, the proposal should make four things clear in one page:

• the specific topic or argument the synthesis will advance

• why the synthesis is needed now (recent immunology paradigm shift, technological inflection, public-health moment)

• what differentiates the proposal from existing reviews on adjacent topics

• why this author team is positioned to write the definitive synthesis

At minimum, the inquiry includes:

• a working title that states the synthesis

• a 200-300 word scope outline

• a "why now" paragraph naming recent immunology developments

• a paragraph distinguishing from existing reviews

• a candidate author list with primary-research credentials

• a proposed length and figure structure

Common failures here are timing and authority failures:

• The proposed topic was reviewed within 24 months. Editors check existing literature before responding.

• The "why now" case is generic. "Recent advances in [immunology topic]" is not a why-now case. Editors look for a specific inflection.

• The angle is not differentiated. A proposal structurally indistinguishable from a recent review even if the topic is technically new.

• The author team lacks primary-research depth. If no proposed author has published primary research in the proposed topic within 5 years, the proposal is typically returned.

NRI is a venue for definitive immunology syntheses, not surveys or original research findings.

The commissioning model: the journal says most of its content is commissioned by its editors, though some articles are proposed by authors. A proposal is the path for author-initiated pieces.

The 24-month timing window (our rule of thumb, not a published journal rule): treat a comprehensive review of the same topic in NRI, Annual Review of Immunology, Immunity Reviews, or Trends in Immunology within the last 24 months as a timing collision.

The breadth standard: the journal serves immunologists across innate, adaptive, cellular, infection, tumor, autoimmunity, and vaccine immunology. A Review useful only to a single sub-discipline is usually redirected.

The proposal needs:

• a synthesis-level argument with cross-subfield implications

• one defensible "why now" inflection point

• author credentials signaling authority on the specific topic

• a clear point of view, not a neutral summary

Before submitting to Nature Reviews Immunology, a Nature Reviews Immunology submission readiness check identifies whether the package meets the editorial bar before you commit to the submission.

The strongest NRI inquiries sound like one editor briefing another on a piece worth commissioning.

They usually:

• state the central argument in one sentence

• explain why the synthesis is needed in this 18-month window

• distinguish from 2-3 existing reviews

• establish author credentials in 2-3 sentences

• propose a working title and section outline

Editors first check whether the inquiry deserves to be commissioned now: the topic timing, the distinct synthesis angle, and the author team's authority. The outline should make those signals obvious before the editor reaches the detailed topic map or candidate figure plan.

• Is Nature Reviews Immunology a good journal?

• Nature Reviews Immunology under consideration

• Nature Reviews Microbiology submission guide

• Endocrine Reviews submission guide for the Article Plan version of a commissioned biomedical review route.

Before drafting the inquiry, run your proposal through a Nature Reviews Immunology pre-submission readiness check.

For a broader file-level scan before upload, use the Manusights AI manuscript review to catch readiness gaps across framing, methods, and journal fit.

Across Manusights submission reviews for immunology review proposals targeting Nature Reviews Immunology, three patterns generate the most consistent inquiry-stage rejections. (Per Nature Reviews Immunology author guidance, proposals should be submitted as a synopsis with a 200-word abstract, main-section outline, key references, and author affiliations;

the journal considers Review-type and Comment-type proposals and does not publish original research, case studies, meta-analyses, or systematic reviews.) These patterns are testable in the proposal abstract, section outline, reference map, author list, figure plan, and cover letter before you contact the Nature Reviews Immunology editors.

Original-research or systematic-review logic disguised as a Nature Reviews proposal

Across Nature Reviews Immunology-targeted manuscripts, the clearest immediate rejection pattern is a proposal whose internal logic still belongs to a primary research article, meta-analysis, systematic review, or case-based clinical paper. Nature Reviews Immunology explicitly says it does not publish original research, case studies, meta-analyses, or systematic reviews.

Editors can see the mismatch in the abstract, methods language, section outline, figure plan, and reference map. Warning signs include a proposal organized around a dataset, cohort, trial subgroup, or PRISMA-style search strategy; a methods section that promises new analysis rather than synthesis; figures that display new results instead of conceptual organization; and a cover letter emphasizing novelty of data rather than novelty of interpretation.

These proposals usually route better to Nature Immunology for primary immunology research, Immunity for mechanistic cellular and molecular immunology, The Journal of Experimental Medicine for disease-mechanism studies, Clinical Immunology for translational clinical papers, Frontiers in Immunology for broader review and mini-review formats, or a systematic-review venue when the method is evidence synthesis rather than invited narrative analysis.

The fix is to remove the primary-data promise, rebuild the synopsis around a field-level argument, make the 200-word abstract state the conceptual shift, and use figures or boxes to organize mechanisms, debates, or practice implications rather than report original findings.

Check whether your NRI inquiry is a synthesis rather than a disguised original study →

Review topic collides with recent NRI, Annual Review, Trends, or Immunity coverage

In our pre-submission review work, the second recurring pattern is timing collision. The proposed Nature Reviews Immunology topic may be important, but a recent comprehensive review has already occupied the synthesis slot. Editors check this quickly through the key-reference list, outline, and "why now" paragraph.

A weak proposal lists recent NRI, Annual Review of Immunology, Trends in Immunology, Immunity, Cell Host & Microbe, or Nature Reviews Disease Primers articles without explaining how the new manuscript changes the frame.

The manuscript components that reveal the problem are a generic "recent advances" title, section headings that mirror a recent review, figures that repeat the same mechanism map, and a cover letter that says the field is fast-moving without naming the specific inflection.

A publishable Nature Reviews Immunology synopsis needs a reason to exist now: a post-trial consensus change, a new immunotherapy class, a revised model of innate-adaptive crosstalk, a vaccine-platform inflection, a disease-area reclassification, or a technology that changes what can be measured.

If no distinct timing case exists, route to Trends in Immunology for a focused opinion, Current Opinion in Immunology for narrower update pieces, Annual Review for annual synthesis, Immunity Reviews for cellular and molecular emphasis, or a specialist review venue where overlap is less fatal.

Check whether your NRI inquiry has timing headroom against recent reviews →

Author team and figure architecture do not prove broad immunology authority

Across Manusights submission reviews for NRI inquiries, the third pattern is a proposal with a plausible topic but an author team or visual plan that does not support a Nature Reviews-level synthesis. Nature Reviews Immunology is read across innate, adaptive, cellular, infection, tumor, autoimmunity, vaccine, and systems immunology audiences. The proposal must show that the authors can synthesize across those boundaries.

Editors can see weakness in the author affiliations, publication record, section assignments, figure captions, and reference balance. Warning signs include one senior author with authority in a narrow subfield but no co-author covering adjacent mechanisms, a reference map dominated by the authors' own papers, figure plans that summarize pathways without comparing competing models, and an outline that serves only one immunology subcommunity.

Stronger inquiries usually assign authors to complementary expertise areas, propose figures that teach mechanism and decision logic, and make the cover letter explain why this team can write the synthesis now. If the team cannot demonstrate that breadth, the better route is a focused Review or Perspective at Trends in Immunology, Mucosal Immunology, Cellular & Molecular Immunology, Frontiers in Immunology, or a disease-area review journal.

The fix is to reshape the author list and figure architecture before submitting, not after an editor asks for a broader angle.

Check whether your Nature Reviews Immunology inquiry is submission-ready →

We reviewed Nature Reviews Immunology's author guidelines, Springer Nature editorial-policy materials for the Nature Reviews family, Clarivate JCR data, and our pre-submission review work on pre-submission inquiries we've reviewed for NRI and adjacent venues (Annual Review of Immunology, Trends in Immunology, Immunity reviews).

This page focuses on the pre-submission inquiry process, what makes a viable proposal, what the editorial screen evaluates, and what should be true before contacting editors. It does not cover review-time interpretation or impact-factor analysis, which belong on separate pages.

Source limitations: Nature Reviews can update commissioning instructions, article-format guidance, editorial policies, and submission-system requirements after this review date, so authors should verify final administrative details against the live author pages before contacting editors. Use this guide for the decision official pages cannot fully answer: whether the proposal has timing headroom, a differentiated synthesis angle, and an author-authority case strong enough for an invitation.

Of the manuscript and inquiry packages our team reviewed across Nature Reviews Immunology and adjacent immunology review venues, the most useful practical screen was not whether the synopsis followed a template.

It was whether the abstract, outline, figure plan, key-reference map, author list, and cover note all proved the same commissioning case: this synthesis is needed now, it is different from recent Nature Reviews Immunology and Annual Review coverage, and this author team has earned the authority to write it. Official guidance explains the submission route; the practical layer authors need is whether the route is worth using for this proposal.

The failure pattern we observe most often is timing: a substantial fraction of inquiries propose topics where a recent comprehensive review already covers the same ground.

This guide tells you what Nature Reviews Immunology editors look for before reviewer assignment, and Manusights checks whether YOUR inquiry passes the commissioning-timing, synthesis-angle, author-authority, broad-immunology readership, figure-plan, reference-map, cover-note, and Nature Reviews routing checks that official Nature guidance cannot evaluate from a generic checklist. Paid Manusights reviews are covered by a 60-day money-back guarantee, and we never train on submitted manuscripts.

How do I submit to Nature Reviews Immunology?

Nature Reviews Immunology says most of its content is commissioned by its editors, and that authors are welcome to propose Review-type and Comment-type articles. A proposal takes the form of a synopsis: a 200-word abstract, a brief description of the main article sections, a list of key references, and the authors with their affiliations. Synopses and manuscripts are submitted through the journal's online submission system, using the link and instructions provided by the editor.

What does Nature Reviews Immunology publish?

Reviews and Perspectives (no fixed word count, since length is agreed with the editor; the abstract is ideally 200 words at most), Comment (usually around 500-600 or 1,000-1,200 words), and Research Highlights (short summaries written by the journal's editors). Original research is not published. The journal serves immunologists who want a synthesis from leading authorities.

Why does Nature Reviews Immunology reject most pre-submission inquiries?

Most rejections involve scope too narrow for a broad immunology readership, timing collisions with recent NRI, Annual Review of Immunology, or Trends in Immunology pieces, undifferentiated angle, or author teams without sustained primary-research records in the proposed area.

Do I need to be a senior PI to publish in Nature Reviews Immunology?

Effectively yes. The journal commissions reviews from researchers with established immunology field reputations. Junior researchers are sometimes co-authors with senior PIs, but proposals from groups without senior immunology track records are rarely accepted.